Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900027477Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of Motherwort in menstrual disorders (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Blood routine examination, Routine urine test and 12 more. Planned start Nov 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900027477.